Current Protocols Editorial Board: Stem Cell Biology

Current Protocols Web Advisory Panel


 

Yukiko Yamashita
Dr. Yamashita is investigating mechanisms how adult stem cells (or tissue-specific stem cells) maintain tissue homeostasis, using the Drosophila male germ line as a model system.

Dr. Yamashita joined LSI in January 2007 as an assistant research professor and assistant professor for the Department of Cell & Developmental Biology at the Medical School. Dr. Yamashita received both her BS and PhD in Biophysics from Kyoto University in Japan, and completed postdoctoral training in Margaret Fuller's laboratory at Stanford University. 


Roger Patient
Prof Patient is one of the leading scientists on the development of blood and the cardiovascular system, with a particular focus on the origins and development of stem cells for these tissues. He has made major contributions to the understanding of the roles played by key signaling pathways and transcription factors. 


Thorsten Schlaeger
Dr. Schlaeger is a renowned expert in mouse genetics, endothelial and hematopoetic developmental biology, and embryonic stem cells. He holds a PhD in Human Biology from Phipps University in Marburg, Germany. He received the prestigious Otto Hahn medal for his work on endothelial specific gene regulation, which was performed in the laboratories of Drs. Werner Risau (Max Planck Institute) and Tom N. Sato (Beth Israel Deaconess Hospital, Boston).

In 1998, Dr. Werner Risau, his PhD supervisor, mentor and friend, succumbed to leukemia at age 44, following an unsuccessful bone marrow transplantation. Motivated by this to study the mechanisms of blood cell development, Dr. Schlaeger joined Dr. Stuart Orkin's laboratory at Children's Hospital, where he worked for four years on the role of the stem cell leukemia gene in endothelial and hematopoetic stem cell formation. After a year working as a Senior Scientist in the mouse genetics group of Cell and Molecular Technologies, Dr. Schlaeger returned to Children's in 2005 to serve as the Head of the Human Embryonic Stem Cell Core Facility within the newly established Stem Cell Program. 


Evan Snyder
Evan Y. Snyder, developmental and child neurologist, is Professor and Director of the Stem Cell and Regeneration Program at Burnham Institute for Medical Research in La Jolla, CA., and the Founder and Director of the Southern California Stem Cell Consortium. He also is Director of the NIH sponsored Human Embryonic Stem Cell Research Center.

Dr. Snyder received his B.A. from the University of Pennsylvania, M.Sc. from Oxford University, and then the combined M.D. and Ph.D. degrees from the University of Pennsylvania. He was a Medical Scientist Training Program Awardee by the National Institutes of Health. His postdoctoral training included a pediatric residency (Chief Resident) at Boston Children's Hospital, neurology residency (Chief Resident) at Harvard Medical School, fellowship in neonatology at Children's Hospital-Boston, and a research fellowship in the Department of Genetics at Harvard Medical School. He is a Fellow of the American Society of Neural Transplantation. He is board certified in pediatrics, perinatal-neonatal medicine, and neurology. His mentors are among the country's most outstanding scientists and clinicians. Appointments in the Boston area were at Harvard Medical School and at Children's, Brigham and Women's, Beth Israel, Winchester, Beverly, and South Shore Hospitals. Currently, he has appointments at the University of California at San Diego and Children's Hospital of San Diego.

His research interests are in the areas of embryology, molecular and cellular basis of neural development, tissue engineering, gene therapy, and embryonic stem cell biology. His research is characterized by a multidisciplinary approach to exploring the biology of stem cells and their role throughout life and therapeutic potential. In addition to his very productive research, he finds time to serve on local, national, and international scientific committees, advisory and editorial boards, and as a reviewer for journals and granting agencies. He is a member of many professional organizations and study sections. He has been very active in the training of fellows, residents, and graduate students. Several of his trainees and laboratory staff have received significant awards. His extensive publication list includes papers, abstracts, reviews, chapters in books, and related education materials. He holds several patents involving possible therapeutic uses of stem cells.

Dr. Snyder's recognition for research includes awards by the University of Pennsylvania, W. Alton Jones Cell Science Center, American Academy of Neurology, Boston Children's Hospital, Harvard Medical School, Society for Pediatric Research, Child Neurology Society, Brain Tumor Society, American Association of Clinical Chemistry, and American Society for Neural Transplantation and Repair. . His speaking schedule has carried him to several European countries, the Far East, and throughout this country. His very lengthy lecture schedule has included many named lectureships.